首页|甲状腺癌组织中TIPE2、LASP1蛋白表达与其临床病理特征及预后的相关性分析

甲状腺癌组织中TIPE2、LASP1蛋白表达与其临床病理特征及预后的相关性分析

扫码查看
目的 探讨甲状腺癌组织内人肿瘤坏死因子α诱导蛋白8样分子2(TIPE2)、LIM和SH3结构域蛋白1(LASP1)表达与其临床病理特征及预后的相关性.方法 回顾性分析81例甲状腺癌患者的临床资料.所有患者采用手术治疗,术中切除病理标本后,再切除距离肿瘤2 cm以上的正常组织作为癌旁标本,术后及时送检.采用免疫组化法检测TIPE2、LASP1表达,比较肿瘤标本及癌旁标本内TIPE2、LASP1表达差异;比较TIPE2、LASP1表达与其临床病理特征相关性及其预后的相关性.结果 肿瘤标本内TIPE2阳性表达率低于癌旁标本,LASP1阳性表达率高于癌旁标本,差异有统计学意义(P<0.05);TIPE2表达阳性组Ⅰ~Ⅱ期、淋巴结无转移、肿瘤直径<2 cm占比高于阴性组,差异有统计学意义(P<0.05);LASP1表达阳性组Ⅲ~Ⅳ期、淋巴结转移、肿瘤直径≥2 cm占比高于阴性组,差异有统计学意义(P<0.05);随访3年,81例患者共31例出现复发转移,预后不良发生率为38.27%(31/81);TIPE2表达阳性组预后不良5例(17.24%),阴性组预后不良26例(50.00%);TIPE2阳性组预后不良率低于阴性组,差异有统计学意义(x2=8.457,P=0.004);LASP1表达阳性组预后不良率(45.00%)高于阴性组(19.05%),差异有统计学意义(x2=4.435,P=0.035).结论 甲状腺癌组织内TIPE2阳性表达率较低,LASP1阳性表达较高,TIPE2、LASP1表达与肿瘤分期、淋巴结转移及肿瘤直径关系密切,且TIPE2低表达、LASP1高表达患者预后较差.
Correlation Between the Expression of TIPE2 and Lasp1 Protein and Clinicopathological Features and Prognosis in Thyroid Carcinoma
Objective To explore human tumor necrosis factor in thyroid cancer tissue α The correlation between the ex-pression of inducible protein 8 like molecule 2(TIPE2),LIM,and SH3 domain protein 1(LASP1)and their clinical pathological characteristics and prognosis.Methods A retrospective analysis was conducted on the clinical data of 81 patients with thyroid cancer.All patients underwent surgical treatment.After removing pathological specimens during the surgery,normal tissue at a dis-tance of more than 2cm from the tumor was removed as a paracancerous specimen,which was promptly sent for examination after the surgery.Immunohistochemical method was used to detect the expression of TIPE2 and LASP1,and the differences in the ex-pression of T1PE2 and LASP1 were compared between tumor specimens and adjacent specimens;Compare the correlation between the expression of TIPE2 and LASP1 with clinical and pathological features,as well as their correlation with prognosis.Results The positive expression rate of TIPE2 in tumor samples was lower than that in adjacent cancer samples,while the positive expres-sion rate of LASP1 was higher than that in adjacent cancer samples,with a statistically significant difference(P<0.05);The pro-portion of patients with positive TIPE2 expression in stages Ⅰ to Ⅱ,no lymph node metastasis,and tumor diameter<2 cm was higher in the positive group than in the negative group,and the difference was statistically significant(P<0.05);The proportion of stage Ⅲ~Ⅳ,lymph node metastasis,and tumor diameter ≥2 cm in the positive group of LASP1 expression was higher than that in the negative group,and the difference was statistically significant(P<0.05);During a 3-year follow-up,31 out of 81 pa-tients experienced recurrence and metastasis,with a poor prognosis rate of 38.27%(31/81);5 cases(17.24%)had poor prog-nosis in the TIPE2 positive group,while 26 cases(50.00%)had poor prognosis in the negative group;The poor prognosis rate of the TIPE2 positive group is lower than that of the negative group,and the difference is statistically significant(x2=8.457,P=0.004);The poor prognosis rate in the positive group of LASP1 expression(45.00%)was higher than that in the negative group(19.05%),and the difference was statistically significant(X2=4.435,P=0.035).Conclusion The positive expression rate of TIPE2 in thyroid cancer tissue is low,while the positive expression of LASP1 is high.The expression of TIPE2 and LASP1 is closely related to tumor stage,lymph node metastasis,and tumor diameter.Patients with low expression of TIPE2 and high expres-sion of LASP1 have poor prognosis.

Thyroid cancerLim and SH3 domain protein 1Pathological featuresClinical prognosis

张瑜、马征泽、王曼、阎芳、周晓燕、刘双双

展开 >

450000 郑州大学第一附属医院

甲状腺癌 LIM和SH3结构域蛋白1 病理特征 临床预后

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(1)
  • 12